Published in Vaccine Weekly, February 16th, 2005
According to recent research published in the Journal of Health Population and Nutrition, "Despite the availability of at least two licensed typhoid fever vaccines - injectable sub-unit Vi polysaccharide vaccine and live, oral Ty21a vaccine - for the last decade, these vaccines have not been widely introduced in public health programs in countries endemic for typhoid fever. The goal of the multidisciplinary DOMI (Diseases of the Most Impoverished) typhoid fever program is to generate policy-relevant data to support public decision-making regarding the introduction of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly